Teva Pharmaceutical Industries
Teva Pharmaceutical Industries Newswire

Teva Pharmaceutical Industries Newswire

Comprehensive Real-Time News Feed for Teva Pharmaceutical Industries.

Results 1 - 20 of 802 in Teva Pharmaceutical Industries

  1. Mylan Holders Approve Perrigo PurchaseRead the original story

    4 hrs ago | NACD

    ... d offer. Mylan has been pursuing Perrigo even while it was the target of a takeover itself by Teva Pharmaceutical Industries Ltd., before Teva opted to acquire Allergan PLC's generics unit instead. Abstract News 2015 INFORMATION, INC.

    Comment?

  2. Several Indian Pharmaceutical Companies Are Joining the Rapidly Growing Global API MarketRead the original story w/Photo

    14 hrs ago | SBWire

    ... Ltd., Lonza Group, Novartis International AG, Mylan, Inc., Pfizer, Inc., WuXi Apptec, and Teva Pharmaceutical Industries Ltd. However, the market consists of more than 2,500 participants, making it highly fragmented in nature. The recent approval of ...

    Comment?

  3. Market Report, 'Multiple Sclerosis Market in the US 2015-2019', publishedRead the original story w/Photo

    15 hrs ago | PR-inside.com

    ... operating in this market. Key Vendors * Bayer AG * Biogen * Merck Serono * Novartis AG * Teva Pharmaceutical Industries Ltd. Other Prominent Vendors * AB Science * Abbvie * Acorda Therapeutics * Active Biotech * Artielle * Astellas * AstraZeneca * ...

    Comment?

  4. Europe bans drugs tested by GVK; FDA monitors but keeps allowing salesRead the original story w/Photo

    17 hrs ago | In-PharmaTechnologist.com

    ... the products. Several companies with US operations, including Abbott Laboratories, Teva Pharmaceutical Industries, and Mylan, were among those whose products appeared on the EMA list. An Abbott spokesman said Abbott doesn't sell any pharmaceutical ...

    Comment?

  5. Teva Pharmaceutical Industries Given BBB- Credit RatingRead the original story w/Photo

    22 hrs ago | AmericanBankingNews.com

    Teva Pharmaceutical Industries has earned a "BBB-" credit rating from Morningstar . The investment research firm's "BBB-" rating suggests that the company is a moderate default risk.

    Comment?

  6. Teva Pharmaceutical Industries Given Buy Rating at Bank of AmericaRead the original story w/Photo

    Sunday | AmericanBankingNews.com

    's stock had its "buy" rating reiterated by Bank of America in a research note issued to investors on Sunday, Market Beat Ratings reports. Shares of Teva Pharmaceutical Industries traded down 0.26% during midday trading on Friday, hitting $65.03.

    Comment?

  7. How The Bank Of Israel Got Its Last Rate Decision WrongRead the original story w/Photo

    Saturday Aug 29 | Seeking Alpha

    Israel's booming housing market and rising budget deficit keep the BOI from lowering rates further, but global economic conditions require actions to devalue the NIS. The recent monetary policy statement of the Bank of Israel didn't offer any big headlines, as the BOI left its cash rate unchanged at 0.1%.

    Comment?

  8. Mylan shareholders approve pursuit of PerrigoRead the original story w/Photo

    Friday Aug 28 | The York Daily Record

    ... approval, Mylan said it plans on launching a formal offer for Perrigo in the coming weeks. Teva Pharmaceutical Industries Ltd. was also pursuing Mylan, but is now buying the generics business of Allergan PLC. for $40.5 billion in a move to expand ...

    Comment?

  9. Mylan Investors Vote to Push Ahead With Hostile Perrigo DealRead the original story

    Friday Aug 28 | The Washington Post

    ... argued the Perrigo deal was a better alternative than accepting a takeover offer from Teva Pharmaceutical Industries Ltd. Teva has since walked away from doing a deal with Mylan in favor of buying Allergan Plc's generics business. Mylan remained ...

    Comment?

  10. The Wall Street Journal: Mylan shareholders approve acquisition of PerrigoRead the original story w/Photo

    Friday Aug 28 | MarketWatch

    ... pursuing Perrigo for months, part of the time while it was a target of a takeover itself by Teva Pharmaceutical Industries Ltd., before Teva Mostly recently, in April, Mylan raised its bid to $35.6 billion from about $33 billion. Then, Mr. Coury ...

    Comment?

  11. FDA Lays Out Naming Rules for Lower-Cost Biotech DrugsRead the original story

    Thursday Aug 27 | P&T Community

    ... Amgen's Neupogen imitation would be called filgrastim-jcwp, and a version of filgrastim that Teva Pharmaceutical Industries makes would be filgrastim-vkzt. Amgen's dialysis drug Epogen and Johnson & Johnson's arthritis treatment Remicade would be ...

    Comment?

  12. What to Call Biologic Copycats? FDA Plans Names And SuffixesRead the original story

    Thursday Aug 27 | The Washington Post

    ... Amgen's Neupogen imitation would be called filgrastim-jcwp. and a version of filgrastim that Teva Pharmaceutical Industries Ltd. makes would be filgrastim-vkzt. Amgen's dialysis drug Epogen and Johnson & Johnson's arthritis treatment Remicade would ...

    Comment?

  13. Global chronic lymphocytic leukemia therapeutics market to grow at a...Read the original story w/Photo

    Wednesday Aug 26 | PR-inside.com

    ... Global Chronic Lymphocytic Leukemia Therapeutics Market: F. Hoffmann-La Roche, Novartis and Teva Pharmaceutical Industries. Other Prominent Vendors in the market are: Actavis, Amgen, Aryogen, Astellas, Bristol-Myers Squibb, Eagle Pharmaceuticals, ...

    Comment?

  14. Open-SCS webinar set for Sept. 3Read the original story

    Wednesday Aug 26 | Packaging World

    ... supply chain standards organizations. The Open-SCS was formed by founding members Abbott, Teva Pharmaceutical Industries Ltd., Famar Health Care Services, Mylan Pharmaceutical, NNEPharmaplan, SAP AG, OptelVision Inc., Systech International, Werum IT ...

    Comment?

  15. Corium International, Inc. To Ring The Stock Market Closing BellRead the original story

    Tuesday Aug 25 | BioSpace

    Corium International, Inc. , a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, will visit the Nasdaq MarketSite in Times Square. Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC 3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at: http://www.facebook.com/NASDAQ .

    Comment?

  16. XTL Biopharmaceuticals Ltd. Announces Publication Of Results Of Phase ...Read the original story

    Tuesday Aug 25 | BioSpace

    XTL Biopharmaceuticals Ltd. , announced today that previously reported results of a Phase 2b study on the safety and efficacy of its lead drug candidate, hCDR1 for the treatment of SLE were published in the Lupus Science & Medicine Journal. See link for full article .

    Comment?

  17. Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2015 UpdateRead the original story w/Photo

    Wednesday Aug 26 | Seeking Alpha

    Glenview Capital Management's 13F portfolio increased from $21.90B to $25.25B. The number of positions increased from 78 to 81. The top-three positions are Humana, Thermo Fisher Scientific, and AbbVie and they add up to almost ~15% of the portfolio.

    Comment?

  18. Biotechnology Market Analysis-Size, Share, Growth, Trends and Forecasts To 2020: Grand View ResearchRead the original story w/Photo

    Tuesday Aug 25 | PR-inside.com

    ... Key industry participants include Novo Nordisk, Amgen, Gilead Sciences, Celgene, Biogen Idic, Teva Pharmaceutical Industries, Merck KGaA, CSL, Regeneron, Alexion Pharmaceuticals, Shire PLC, Vertex Pharmaceuticals, BioMarin Pharmaceutical, Elan, ...

    Comment?

  19. Eli Lilly says court rules in its favor on Alimta patentRead the original story w/Photo

    Tuesday Aug 25 | Seeking Alpha

    Eli Lilly says a U.S. federal court ruled that generic products proposed by a unit of Teva Pharmaceutical would infringe a U.S. patent for LLY's blockbuster cancer drug Alimta.

    Comment?

  20. Teva Pharmaceutical Industries Limited (TEVA) - Medical Equipment - Deals and Alliances ProfileRead the original story w/Photo

    Tuesday Aug 25 | PR-inside.com

    Teva Pharmaceutical Industries Limited is a fully integrated global pharmaceutical company. It undertakes the development, manufacture and marketing of a wide range of generic and branded pharmaceuticals and active pharmaceutical ingredients .

    Comment?